What's dragging the Incannex (ASX:IHL) share price 5% lower today?

The medicinal cannabis producer is having a bad day after releasing an update on its potential listing in the US.

| More on:
Falling cannabis asx share price represented by cannabis leaves on a declining line graph

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Incannex Healthcare Ltd (ASX: IHL) share price is in the red today after a company update on its potential NASDAQ listing.

Shares in the medicinal cannabis company were swapping hands at 47.5 cents at the time of writing, down 5%.

Let's delve into what might be weighing on the Incannex share price today.

What did the company announce?

Incannex is planning an initial public offering (IPO) on the United States NASDAQ exchange early next year under the ticker NASDAQ: IXHL.

As reported by my Foolish colleague Zach, the company filed the F-1 form for listing with the US Securities and Exchange Commission back in August.

However, the company advised today that shareholder approval for the issue of 180 million shares as part of the offering had now expired.

The number and price of the American Depositary Shares to be issued under the potential offering still needs to be decided.

Despite this, Incannex informed investors it was still in a position to conduct an offering in January 2022.

The company told investors it had taken several months to address comments raised by the US Securities and Exchange Commission. However, these issues have now been "adequately addressed".

The company is seeking a dual listing, so Incannex shares will continue to be listed on the ASX during and after the potential US offering.

Management comment

Commenting on today's update, CEO and managing director Joel Latham said:

We are grateful to our team for their work on the registration process and now look forward to marketing the offering and listing on Nasdaq in January when institutional investors are back on deck after the relatively short winter holiday period in the northern hemisphere.

It's been a momentous year for Incannex with six research and development programs that continue to progress rapidly.

Incannex Healthcare share price snapshot

The Incannex share price has gained a whopping 206% since January this year.

However, shares in the company have dived nearly 10% in the past week and 15% in the last month.

Based on the current share price, Incannex has a market capitalisation of roughly $574 million.

The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cannabis Shares

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Cannabis Shares

Why are these 2 ASX cannabis stocks sputtering today?

Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Cannabis Shares

Guess which ASX cannabis share is crashing 36% following an FDA blow

Rookie mistake: This cannabis share just missed out on FDA approval for a simple reason.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Could ASX cannabis shares be set for a resurgence?

The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Cannabis Shares

This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!

Investors are very excited about this cannabis stock.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

Read more »

A hip young man with a beard and manbun sits thoughtfully at his laptop computer in a darkened room, staring at the screen with his chin resting on his hand in thought.
Cannabis Shares

Should I buy Incannex shares while they're at multi-year lows, or steer clear?

Is the cannabis-based pharma company a bargain buy right now?

Read more »

Man in the green house growing medical cannabis
Cannabis Shares

A $3k investment in ASX cannabis stock Incannex 5 years ago is now worth $15,000. Here's why

This medicinal cannabis company has been a rare winner in its field.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Cannabis Shares

Which ASX cannabis share is surging 27% on record quarterly results?

Althea CEO Josh Fegan has declared "a landmark turning point" for the company.

Read more »